SHANGHAI, China, May 26 /Xinhua-PRNewswire/ -- WuXi PharmaTech (NYSE:
WX), a leading pharmaceutical, biotechnology and medical device research
and development outsourcing company with operations in China and the United
States, today proudly announced that it has appointed Dr. Peng Wang as Vice
President of Discovery Biology.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
Prior to joining WuXi PharmaTech, Dr. Wang was a research fellow at
Schering-Plough Research Institute where he worked for 18 years with
increasing responsibilities. He has extensive experience in discovery
biology, including target validation research, assay development,
screening, in vitro and in vivo biological and pharmacological studies, and
mechanism of action and biomarker research. As a discovery team co-chair
and biology group leader at Schering-Plough, Dr. Wang made significant
contributions to the nomination of several development candidates, four of
which are at various phases of clinical trial.
In his new role as Vice President of Discovery Biology, Dr. Wang will
oversee the company's growing portfolio of discovery biology service
offerings. Dr. Wang will report directly to Dr. Ge Li, Chairman and Chief
Executive Officer of WuXi PharmaTech.
"I am very delighted to welcome Dr. Wang on board at this exciting
time. Dr. Wang's depth of experience will undoubtedly help the company to
accelerate the development of our discovery biology services, and
strengthen our medicinal chemistry and biologics discovery capabilities,"
commented Dr. Ge Li, Chairman and Chief Executive Officer of WuXi
Dr. Wang received his Ph.D. in Biochemistry from the University of
Tokyo, Japan, and has published numerous original biological research
articles in the leading and peer-reviewed scientific journals.
About WuXi PharmaTech
WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical
device R&D outsourcing company, with operations in China and the United
States. As a research-driven and customer-focused company, WuXi PharmaTech
provides pharmaceutical, biotechnology and medical device companies a broad
and integrated portfolio of laboratory and manufacturing services
throughout the drug and medical device R&D process. WuXi PharmaTech's
services are designed to assist its global partners in shortening the cycle
and lowering the cost of drug and medical device R&D. For more information,
please visit: http://www.wuxipharmatech.com .
For more information, please contact:
SOURCE WuXi PharmaTech